KittyHawk
KittyHawk is a venture capital firm based in Santa Monica, California, founded in 2015. It focuses on leading-edge seed to late-stage pre-IPO companies and supports mission-driven entrepreneurs building world-changing organizations. The firm operates two primary strategies: KittyHawk Frontier, which targets seed-stage investments across frontier technologies such as AI, quantum computing, aerospace, healthcare, longevity, climate, and Web3; and KittyHawk Secondaries, which are pre-IPO secondary funds that leverage relationships with Nasdaq Private Markets to access late-stage opportunities. The firm is led by Will Weisman, a former executive director of Singularity University.
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Series H
InflammaSense
Funding Round in 2023
InflammaSense, now known as VitalX, is a health technology company focused on early detection of sepsis and other inflammatory diseases by leveraging the vagus nerve's capabilities. The company develops a discreet device that continuously monitors traditional biological signals such as electrocardiogram (ECG), respiratory rate, and oxygen saturation. In addition to these conventional metrics, VitalX's innovative device incorporates a patent-pending neural signal that facilitates the timely identification of sepsis. By transmitting early alarms to clinicians, the technology aims to enhance patient outcomes and enable healthcare professionals to make critical, life-saving decisions more effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.